You can purchase shares of Nordicus Partners (NASDAQ:NORD) through any online brokerage.
Other companies in Nordicus Partners’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
There is no analysis for Nordicus Partners to provide a consensus price target.
The stock price for Nordicus Partners (NASDAQ: NORD) is $3.96 last updated November 4, 2026 at 6:48 PM EST.
There are no upcoming dividends for Nordicus Partners.
Nordicus Partners does not have any upcoming earnings scheduled.
There is no upcoming split for Nordicus Partners.
Nordicus Partners is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Nordicus Partners Corp specializes in developing breakthrough therapeutics for diseases with unmet medical needs. The Company focuses on acquiring and developing drugs from biotech companies in the Nordics, a region known for its scientists, life...